Arch Therapeutics Inc (fka ARTHQ)

[jtsmgoblue]

Only opinion that matters is informed opinion. Here are some facts to help you understand.

https://www.slideshare.net/mobile/capgemini/pharmaceutical-mergers-acquisitions-in-the-us
See slides 4-6

Other recent baby bios meeting the criteria are cpxx, armo bioscience and ablynx.

Nothing is for certain but time from FDA approval is one key metric for the timing of M & A in this space. Key drivers enabling this timing are cheap financing, taxes, shareholder satisfaction, competitive advantage, reduced r&d (already baby bio funded), and patent lapse.

Sit tight and watch and learn. Nothing is for certain but you can bet arch leaders are engaged in talks. That’s how it works in this industry esp for capital strapped, no structural composition to make / distribute / market.